FGF21 and autophagy coordinately counteract kidney disease progression during aging and obesity

References

• Jager KJ, Kovesdy C, Langham R, et al. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int. 2019 Nov;96(5):1048–1050. doi: 10.1016/j.kint.2019.07.012
   PubMed Web of Science ®Google Scholar
• Global, regional, and znational age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the global burden of disease study 2013. Lancet. 2015 Jan 10;385(9963):117–171. doi: 10.1016/S0140-6736(14)61682-2
   PubMedGoogle Scholar
• Rhee CM, CP K. Epidemiology: spotlight on CKD deaths—increasing mortality worldwide. Nat Rev Nephrol. 2015 Apr;11(4):199–200. doi: 10.1038/nrneph.2015.25
   PubMed Web of Science ®Google Scholar
• Breyer MD, Susztak K. The next generation of therapeutics for chronic kidney disease. Nat Rev Drug Discov. 2016 Aug;15(8):568–588. doi: 10.1038/nrd.2016.67
   PubMed Web of Science ®Google Scholar
• Little MH, Humphreys BD. Regrow or repair: an update on potential regenerative therapies for the kidney. J Am Soc Nephrol. 2022 Jan;33(1):15–32. doi: 10.1681/ASN.2021081073
   PubMed Web of Science ®Google Scholar
• Mizushima N, Levine B, Cuervo AM, et al. Autophagy fights disease through cellular self-digestion. Nature. 2008 Feb 28;451(7182):1069–1075. doi: 10.1038/nature06639
   PubMed Web of Science ®Google Scholar
• Kimura T, Takabatake Y, Takahashi A, et al. Autophagy protects the proximal tubule from degeneration and acute ischemic injury. J Am Soc Nephrol. 2011 May;22(5):902–913. doi: 10.1681/ASN.2010070705
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Takabatake Y, Kimura T, et al. Time-dependent dysregulation of autophagy: implications in aging and mitochondrial homeostasis in the kidney proximal tubule. Autophagy. 2016 May 3;12(5):801–813. doi: 10.1080/15548627.2016.1159376
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Takabatake Y, Takahashi A, et al. High-fat diet-induced lysosomal dysfunction and impaired autophagic flux contribute to lipotoxicity in the kidney. J Am Soc Nephrol. 2017 May;28(5):1534–1551. doi: 10.1681/ASN.2016070731
   PubMed Web of Science ®Google Scholar
• Takahashi A, Takabatake Y, Kimura T, et al. Autophagy inhibits the accumulation of advanced glycation end products by promoting lysosomal biogenesis and function in the kidney proximal tubules. Diabetes. 2017 May;66(5):1359–1372. doi: 10.2337/db16-0397
   PubMed Web of Science ®Google Scholar
• Sakai S, Yamamoto T, Takabatake Y, et al. Proximal tubule autophagy differs in type 1 and 2 Diabetes. J Am Soc Nephrol. 2019 Jun;30(6):929–945. doi: 10.1681/ASN.2018100983
   PubMed Web of Science ®Google Scholar
• Bordi M, Berg MJ, Mohan PS, et al. Autophagy flux in CA1 neurons of alzheimer hippocampus: increased induction overburdens failing lysosomes to propel neuritic dystrophy. Autophagy. 2016 Dec;12(12):2467–2483. doi: 10.1080/15548627.2016.1239003
   PubMed Web of Science ®Google Scholar
• Takabatake Y, Yamamoto T, Isaka Y. Stagnation of autophagy: a novel mechanism of renal lipotoxicity. Autophagy. 2017 Apr 3;13(4):775–776. doi: 10.1080/15548627.2017.1283084
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Takabatake Y, Minami S, et al. Eicosapentaenoic acid attenuates renal lipotoxicity by restoring autophagic flux. Autophagy. 2021 Jul;17(7):1700–1713. doi: 10.1080/15548627.2020.1782034
   PubMed Web of Science ®Google Scholar
• Yamamoto-Imoto H, Minami S, Shioda T, et al. Age-associated decline of MondoA drives cellular senescence through impaired autophagy and mitochondrial homeostasis. Cell Rep. 2022 Mar 1;38(9):110444. doi: 10.1016/j.celrep.2022.110444
   PubMed Web of Science ®Google Scholar
• Kharitonenkov A, DiMarchi R. Fibroblast growth factor 21 night watch: advances and uncertainties in the field. J Intern Med. 2017 Mar;281(3):233–246. doi: 10.1111/joim.12580
   PubMed Web of Science ®Google Scholar
• Xie T, Leung PS. Fibroblast growth factor 21: a regulator of metabolic disease and health span. Am J Physiol Endocrinol Metab. 2017 Sep 1;313(3):E292–E302. doi: 10.1152/ajpendo.00101.2017
   PubMed Web of Science ®Google Scholar
• Ye D, Wang Y, Li H, et al. Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1alpha-mediated antioxidant capacity in mice. Hepatology. 2014 Sep;60(3):977–989. doi: 10.1002/hep.27060
   PubMed Web of Science ®Google Scholar
• Kim SH, Kim KH, Kim HK, et al. Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress. Diabetologia. 2015 Apr;58(4):809–818. doi: 10.1007/s00125-014-3475-6
   PubMed Web of Science ®Google Scholar
• Hojman P, Pedersen M, Nielsen AR, et al. Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia. Diabetes. 2009 Dec;58(12):2797–2801. doi: 10.2337/db09-0713
   PubMed Web of Science ®Google Scholar
• Kim KH, Jeong YT, Oh H, et al. Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine. Nat Med. 2013 Jan;19(1):83–92. doi: 10.1038/nm.3014
   PubMed Web of Science ®Google Scholar
• Planavila A, Redondo I, Hondares E, et al. Fibroblast growth factor 21 protects against cardiac hypertrophy in mice. Nat Commun. 2013;4(1):2019. doi: 10.1038/ncomms3019
   PubMedGoogle Scholar
• Salminen A, Kaarniranta K, Kauppinen A. Regulation of longevity by FGF21: interaction between energy metabolism and stress responses. Ageing Res Rev. 2017 May 25;37:79–93. doi: 10.1016/j.arr.2017.05.004
   PubMed Web of Science ®Google Scholar
• Youm YH, Horvath TL, Mangelsdorf DJ, et al. Prolongevity hormone FGF21 protects against immune senescence by delaying age-related thymic involution. Proc Natl Acad Sci U S A. 2016 Jan 26;113(4):1026–1031. doi: 10.1073/pnas.1514511113
   PubMed Web of Science ®Google Scholar
• Jimenez V, Jambrina C, Casana E, et al. FGF21 gene therapy as treatment for obesity and insulin resistance. EMBO Mol Med. 2018 Aug;10(8):e8791. doi: 10.15252/emmm.201708791
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xie Y, Berglund ED, et al. The starvation hormone, fibroblast growth factor-21, extends lifespan in mice. Elife. 2012 Oct 15;1:e00065. doi: 10.7554/eLife.00065
   PubMed Web of Science ®Google Scholar
• Kim HW, Lee JE, Cha JJ, et al. Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice. Endocrinology. 2013 Sep;154(9):3366–3376. doi: 10.1210/en.2012-2276
   PubMed Web of Science ®Google Scholar
• Zhang C, Shao M, Yang H, et al. Attenuation of hyperlipidemia- and diabetes-induced early-stage apoptosis and late-stage renal dysfunction via administration of fibroblast growth factor-21 is associated with suppression of renal inflammation. PLoS One. 2013;8(12):e82275. doi: 10.1371/journal.pone.0082275
   PubMed Web of Science ®Google Scholar
• Minami S, Yamamoto T, Takabatake Y, et al. Lipophagy maintains energy homeostasis in the kidney proximal tubule during prolonged starvation. Autophagy. 2017 Oct 3;13(10):1629–1647. doi: 10.1080/15548627.2017.1341464
   PubMed Web of Science ®Google Scholar
• Loeffler I, Hopfer U, Koczan D, et al. Type VIII collagen modulates TGF-β1-induced proliferation of mesangial cells. J Am Soc Nephrol. 2011 Apr;22(4):649–663. doi: 10.1681/ASN.2010010098
   PubMed Web of Science ®Google Scholar
• Li F, Liu Z, Tang C, et al. FGF21 is induced in cisplatin nephrotoxicity to protect against kidney tubular cell injury. FASEB J. 2018 Jun;32(6):3423–3433. doi: 10.1096/fj.201701316R
   PubMed Web of Science ®Google Scholar
• Kawamoto S, Niwa H, Tashiro F, et al. A novel reporter mouse strain that expresses enhanced green fluorescent protein upon Cre-mediated recombination. FEBS Lett. 2000 Mar 31;470(3):263–268. doi: 10.1016/S0014-5793(00)01338-7
   PubMed Web of Science ®Google Scholar
• Docherty MH, O’Sullivan ED, Bonventre JV, et al. Cellular senescence in the kidney. J Am Soc Nephrol. 2019 May;30(5):726–736. doi: 10.1681/ASN.2018121251
   PubMed Web of Science ®Google Scholar
• Tang C, Cai J, Yin XM, et al. Mitochondrial quality control in kidney injury and repair. Nat Rev Nephrol. 2021 May;17(5):299–318. doi: 10.1038/s41581-020-00369-0
   PubMed Web of Science ®Google Scholar
• Cybulsky AV. Endoplasmic reticulum stress, the unfolded protein response and autophagy in kidney diseases. Nat Rev Nephrol. 2017 Nov;13(11):681–696. doi: 10.1038/nrneph.2017.129
   PubMed Web of Science ®Google Scholar
• Yan J, Wang J, Huang H, et al. Fibroblast growth factor 21 delayed endothelial replicative senescence and protected cells from H(2)O(2)-induced premature senescence through SIRT1. Am J Transl Res. 2017;9(10):4492–4501.
   PubMed Web of Science ®Google Scholar
• Chen Q, Ma J, Yang X, et al. SIRT1 mediates effects of FGF21 to ameliorate cisplatin-induced acute kidney injury. Front Pharmacol. 2020;11:241. doi: 10.3389/fphar.2020.00241
   PubMed Web of Science ®Google Scholar
• Yuan X, Wei G, You Y, et al. Rutin ameliorates obesity through brown fat activation. FASEB J. 2017 Jan;31(1):333–345. doi: 10.1096/fj.201600459rr
   PubMed Web of Science ®Google Scholar
• Zhang C, He X, Sheng Y, et al. Allicin regulates energy homeostasis through brown adipose tissue. iScience. 2020 May 22;23(5):101113. doi: 10.1016/j.isci.2020.101113
   PubMed Web of Science ®Google Scholar
• Canto C, Gerhart-Hines Z, Feige JN, et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature. 2009 Apr 23;458(7241):1056–1060. doi: 10.1038/nature07813
   PubMed Web of Science ®Google Scholar
• Croon M, Szczepanowska K, Popovic M, et al. FGF21 modulates mitochondrial stress response in cardiomyocytes only under mild mitochondrial dysfunction. Sci Adv. 2022 Apr 8;8(14):eabn7105. doi: 10.1126/sciadv.abn7105
   PubMed Web of Science ®Google Scholar
• McWilliams TG, Prescott AR, Allen GF, et al. Mito-QC illuminates mitophagy and mitochondrial architecture in vivo. J Cell Bio. 2016 Aug 1;214(3):333–345. doi: 10.1083/jcb.201603039
   PubMed Web of Science ®Google Scholar
• Ishii K, Kobayashi H, Taguchi K, et al. Kidney epithelial targeted mitochondrial transcription factor a deficiency results in progressive mitochondrial depletion associated with severe cystic disease. Kidney Int. 2021 Mar;99(3):657–670. doi: 10.1016/j.kint.2020.10.013
   PubMed Web of Science ®Google Scholar
• Chung KW, Dhillon P, Huang S, et al. Mitochondrial damage and activation of the STING pathway lead to renal inflammation and fibrosis. Cell Metab. 2019 Oct 1;30(4):784–799 e5. doi: 10.1016/j.cmet.2019.08.003
   PubMed Web of Science ®Google Scholar
• Fisher FM, Chui PC, Antonellis PJ, et al. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes. 2010 Nov;59(11):2781–2789. doi: 10.2337/db10-0193
   PubMed Web of Science ®Google Scholar
• So WY, Cheng Q, Chen L, et al. High glucose represses β-klotho expression and impairs fibroblast growth factor 21 action in mouse pancreatic islets: involvement of peroxisome proliferator-activated receptor γ signaling. Diabetes. 2013 Nov;62(11):3751–3759. doi: 10.2337/db13-0645
   PubMed Web of Science ®Google Scholar
• Díaz-Delfín J, Hondares E, Iglesias R, et al. TNF-α represses β-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway. Endocrinology. 2012 Sep;153(9):4238–4245. doi: 10.1210/en.2012-1193
   PubMed Web of Science ®Google Scholar
• Hanks LJ, Gutiérrez OM, Bamman MM, et al. Circulating levels of fibroblast growth factor-21 increase with age independently of body composition indices among healthy individuals. J Clin Transl Endocrinol. 2015 Jun 1;2(2):77–82. doi: 10.1016/j.jcte.2015.02.001
   PubMedGoogle Scholar
• Xia S, Zhang X, Zheng S, et al. An update on inflamm-aging: mechanisms, prevention, and treatment. J Immunol Res. 2016;2016:8426874. doi: 10.1155/2016/8426874
   PubMed Web of Science ®Google Scholar
• Stein S, Bachmann A, Lössner U, et al. Serum levels of the adipokine FGF21 depend on renal function. Diabetes Care. 2009 Jan;32(1):126–128. doi: 10.2337/dc08-1054
   PubMed Web of Science ®Google Scholar
• Lin Z, Zhou Z, Liu Y, et al. Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese. PLoS One. 2011;6(4):e18398. doi: 10.1371/journal.pone.0018398
   PubMed Web of Science ®Google Scholar
• Hindricks J, Ebert T, Bachmann A, et al. Serum levels of fibroblast growth factor-21 are increased in chronic and acute renal dysfunction. Clin Endocrinol (Oxf). 2014 Jun;80(6):918–924. doi: 10.1111/cen.12380
   PubMed Web of Science ®Google Scholar
• Lee CH, Hui EY, Woo YC, et al. Circulating fibroblast growth factor 21 levels predict progressive kidney disease in subjects with type 2 diabetes and normoalbuminuria. J Clin Endocrinol Metab. 2015 Apr;100(4):1368–1375. doi: 10.1210/jc.2014-3465
   PubMed Web of Science ®Google Scholar
• Ruperez C, Lerin C, Ferrer-Curriu G, et al. Autophagic control of cardiac steatosis through FGF21 in obesity-associated cardiomyopathy. Int J Cardiol. 2018 Jun 1;260:163–170. doi: 10.1016/j.ijcard.2018.02.109
   PubMed Web of Science ®Google Scholar
• Zhu S, Wu Y, Ye X, et al. FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy. Mol Cell Biochem. 2016 Sep;420(1–2):107–119. doi: 10.1007/s11010-016-2774-2
   PubMed Web of Science ®Google Scholar
• Cheng STW, SYT L, Leung PS. Fibroblast growth factor 21 stimulates pancreatic islet autophagy via inhibition of AMPK-mTOR signaling. Int J Mol Sci. 2019 May 22;20(10):2517. doi: 10.3390/ijms20102517
   PubMed Web of Science ®Google Scholar
• Zhou K, Chen H, Lin J, et al. FGF21 augments autophagy in random-pattern skin flaps via AMPK signaling pathways and improves tissue survival. Cell Death Dis. 2019 Nov 18;10(12):872. doi: 10.1038/s41419-019-2105-0
   PubMedGoogle Scholar
• Zhang J, Cheng Y, Gu J, et al. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of type 1 diabetic mice. Clin Sci. 2016 Apr;130(8):625–641. doi: 10.1042/CS20150623
   Web of Science ®Google Scholar
• Pandey UB, Nie Z, Batlevi Y, et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature. 2007 Jun 14;447(7146):859–863. doi: 10.1038/nature05853
   PubMed Web of Science ®Google Scholar
• Massey AC, Kaushik S, Sovak G, et al. Consequences of the selective blockage of chaperone-mediated autophagy. Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5805–5810. doi: 10.1073/pnas.0507436103
   PubMed Web of Science ®Google Scholar
• Planavila A, Redondo-Angulo I, Ribas F, et al. Fibroblast growth factor 21 protects the heart from oxidative stress. Cardiovasc Res. 2015 Apr 1;106(1):19–31. doi: 10.1093/cvr/cvu263
   PubMed Web of Science ®Google Scholar
• Wang XM, Xiao H, Liu LL, et al. FGF21 represses cerebrovascular aging via improving mitochondrial biogenesis and inhibiting p53 signaling pathway in an AMPK-dependent manner. Exp Cell Res. 2016 Aug 15;346(2):147–156. doi: 10.1016/j.yexcr.2016.06.020
   PubMed Web of Science ®Google Scholar
• Li X, Hong Y, He H, et al. FGF21 mediates mesenchymal stem Cell senescence via Regulation of mitochondrial Dynamics. Oxid Med Cell Longev. 2019;2019:4915149. doi: 10.1155/2019/4915149
   PubMed Web of Science ®Google Scholar
• Li S, Zhu Z, Xue M, et al. Fibroblast growth factor 21 protects the heart from angiotensin II-induced cardiac hypertrophy and dysfunction via SIRT1. Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1241–1252. doi: 10.1016/j.bbadis.2019.01.019
   PubMed Web of Science ®Google Scholar
• Liu X, Wang Y, Hou L, et al. Fibroblast growth factor 21 (FGF21) promotes formation of aerobic myofibers via the FGF21-SIRT1-AMPK-PGC1alpha pathway. J Cell Physiol. 2017 Jul;232(7):1893–1906. doi: 10.1002/jcp.25735
   PubMed Web of Science ®Google Scholar
• Nakamura J, Yamamoto T, Takabatake Y, et al. TFEB-mediated lysosomal exocytosis alleviates high-fat diet-induced lipotoxicity in the kidney. JCI Insight. 2023 Feb 22;8(4). doi: 10.1172/jci.insight.162498
   Web of Science ®Google Scholar
• Matsui I, Ito T, Kurihara H, et al. Snail, a transcriptional regulator, represses nephrin expression in glomerular epithelial cells of nephrotic rats. Lab Invest. 2007 Mar;87(3):273–283. doi: 10.1038/labinvest.3700518
   PubMed Web of Science ®Google Scholar